Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
May 31, 2000

Sanofi Pharmaceutical Recalls NeGram Suspension Manufactured by Bayer

New York, NY (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Sanofi Pharmaceutical is conducting a recall of NeGram Suspension (Nalidixic Acid Oral Suspension, USP), 250 mg/5mL, in 1 pint bottles (Manufactured by Bayer Corporation) - because of superpotency (at stability - 12 months).

The product is a prescription medication indicated for the treatment of urinary tract infections

FDA stated in its report that 1,200 units were distributed Nationwide and in Canada.  The firm estimated that 60 units remained on market at time of recall initiation.

This ongoing Class III recall was initiated by the company, by letter dated April 20, 2000.  This is the first public notice issued by the FDA.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-388-0
NDC #0024-1318-06

Notice of this product warning was sent via email to SafeMail subscribers May 31, 2000.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.

###

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.